Jason is a consultant and biomedical researcher performing market analyses for pipeline and in-line biopharmaceuticals across various therapeutic areas. At Adivo, now Acumetis, he conducts qualitative and quantitative research projects and supports the continued growth of the Company’s longstanding expertise in immunology, particularly for the US market. Before Adivo, he was a Consultant with ClearView Healthcare Partners, a boutique life science consulting firm focused on generating commercial strategies for early clinical-stage therapeutics. He performed projects in markets within the respiratory, hematology, infectious disease, ophthalmology, and urology spaces focused on the franchise and asset levels.
Projects on the franchise level included a 10-year forward-looking assessment of the growth strategy for a Company’s respiratory franchise and an indication triage for a differentiated gene therapy platform. Asset-level projects included buy-side diligence and product profile testing to inform go/no-go decisions for pivotal clinical trials.